Our study for the first time suggested that SIRT1 deficiency in bladder cancer cells could suppress proliferation and ROS production, as well as induce cell cycle arrest, possibly via the FOXO3a-mediated pathways. The gene discussed is SIRT1; the disease is urinary bladder carcinoma.